Stylianos T. Panopoulos

MikrasAsias 75 Street
Athens, ESYE31 11527, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Journal: Clinical rheumatology

Published: May 14, 2026

Long-term safety and pulmonary function stabilization with nintedanib in systemic sclerosis-associated interstitial lung disease, 2020-2025: a real-world retrospective study from a reference centre.

Long-term safety and pulmonary function stabilization with nintedanib in systemic sclerosis-associated interstitial lung disease, 2020-2025: a real-world retrospective study from a reference centre.

Journal: Rheumatology international

Published: April 12, 2026

Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.

Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.

Journal: Autoimmunity reviews

Published: March 11, 2026

Lung cancer risk in systemic sclerosis: data from an inception cohort and meta-analysis of published studies.

Lung cancer risk in systemic sclerosis: data from an inception cohort and meta-analysis of published studies.

Journal: Clinical and experimental rheumatology

Published: December 31, 2025

Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study.

Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study.

Journal: Rheumatology international

Published: June 19, 2024

Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies.

Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies.

Journal: Frontiers in medicine

Published: February 27, 2024

Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.

Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.

Journal: Rheumatology international

Published: January 09, 2024

Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study.

Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study.

Journal: RMD open

Published: August 03, 2023

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.

Journal: Clinical rheumatology

Published: June 02, 2023

Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

Journal: Arthritis care & research

Published: March 31, 2023

Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of Age.

Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of Age.

Journal: International journal of molecular sciences

Published: February 14, 2023

Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study.

Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study.

Journal: Rheumatology (Oxford, England)

Published: January 14, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026